Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PBE vs. GNOM: which is better?

Bottom line

PBE vs GNOM: the short answer

PBE (Invesco Biotechnology & Genome ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 22% of their top holdings (by weight) are shared.

GNOM is cheaper at 0.5% vs 0.59% — a difference of $9.00 a year per $10,000 invested.

Over five years, PBE returned +3.4% a year vs −13.3% for GNOM.

Updated Nov 19, 2026

PBE vs GNOM side by side

PBEGNOM
TypeETFETF
Fund familyInvescoGlobal X
CategoryTechnology SectorTechnology Sector
Expense ratio0.59%0.5%
Annual cost per $10k$59$50
10-yr cost on $10k (prospectus)$738$628
Max front loadNoneNone
12b-1 fee—0%
1-yr return+24.7%+19.0%
5-yr return (annualized)+3.4%−13.3%
10-yr return (annualized)+5.2%—
Best quarter+25.3%+38.8%
Worst quarter−24.3%−24.2%
Net assets (fund)$281.9M$55.8M
Number of holdings3351
Portfolio turnover103%34%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPBEGNOMDifference
2025+24.7%+19.0%+5.7%
2024+1.1%−16.2%+17.3%
2023+3.7%−8.6%+12.3%
2022−10.8%−36.1%+25.3%
2021+1.6%−16.0%+17.5%
2020+25.5%+51.6%−26.1%

Source: Fund prospectus bar charts

Holdings overlap

7 of PBE's top 25 holdings also appear in GNOM's top 25.

Shared top holdings
HoldingPBEGNOM
Vertex Pharmaceuticals Inc.4.99%3.95%
Gilead Sciences, Inc.4.43%1.95%
Bio-Techne Corp.3.73%3.41%
Illumina, Inc.3.51%4.82%
Qiagen N.V.2.89%3.54%
BioMarin Pharmaceutical Inc.2.82%4.09%
Veracyte, Inc.2.60%3.64%

Source: SEC Form N-PORT

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

GNOM top 10

  1. Guardant Health, Inc. — 5.59%
  2. Illumina, Inc. — 4.82%
  3. Natera, Inc. — 4.15%
  4. Biomarin Pharmaceutical Inc. — 4.09%
  5. Arrowhead Pharmaceuticals, Inc. — 4.07%
  6. Legend Biotech Corp — 4.05%
  7. Praxis Precision Medicines Inc — 4.01%
  8. Twist Bioscience Corp — 3.97%
  9. Vertex Pharmaceuticals Incorporated — 3.95%
  10. CRISPR Therapeutics AG — 3.85%

FAQ

What is the difference between PBE and GNOM?
PBE (Invesco Biotechnology & Genome ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 22% of their top holdings (by weight) are shared. GNOM is cheaper at 0.5% vs 0.59% — a difference of $9.00 a year per $10,000 invested.
Which is cheaper, PBE or GNOM?
GNOM has the lower expense ratio (0.5%).
Should I own both PBE and GNOM?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.